Mkts

Viking Therapeutics, Inc.

NASDAQ: VKTX
$26.17-0.71 (-2.64%)
As of Nov 18, 4:00 PM ET

Key statistics

Day range
26.1627.36
52-week range
23.8243.10
Today
Open26.81
Previous close26.17
Volume5.14M
Valuation
Market cap3.39B
P/E ratio—
EPS (TTM)-4.66
Income & risk
Dividend / yield—
Beta0.81
Avg volume4.27M
Discussion

VKTX News

Stories mentioning VKTX from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development150,150153,45889,95360,15341,39130,98722,78523,769
Sales General & Admin
Total Operating Expenses164,125164,73898,56174,57455,46946,23836,55634,054
Operating Income (Loss)(164,125)(164,738)(98,561)(74,574)(55,469)(46,238)(36,556)(34,054)
Interest Income
Interest Expense
Other Expense5,8007,0767,7749,0139,84010,82111,61611,804
Pretax Income
Tax Provision
Net Income (Loss)(158,325)(157,662)(90,787)(65,561)(45,629)(35,417)(24,940)(22,250)
Earnings Per Share (Basic)(1.37)(1.40)(0.81)(0.58)(0.41)(0.32)(0.22)(0.20)
Earnings Per Share (Diluted)(1.37)(1.40)(0.81)(0.58)(0.41)(0.32)(0.22)(0.20)
Weighted Average Shares Outstanding (Basic)115,568112,667112,320112,134112,069109,037110,911110,390
Weighted Average Shares Outstanding (Diluted)115,568112,667112,320112,134112,069109,037110,911110,390

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VKTX

Viking Therapeutics, Inc. (NASDAQ: VKTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol VKTX. It last traded at $26.17 (Nov 18, 2026, 4:00 PM ET), down 2.6% on the day. That gives Viking Therapeutics a market capitalisation of $3.4B.

Over the past 52 weeks VKTX has traded between $23.82 and $43.10.

Revenue for the quarter ended Mar 31, 2026 was $0; a net loss of $158.3M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026$0-$158.3M
Dec 31, 2025$0-$157.7M
Sep 30, 2025$0-$90.8M
Jun 30, 2025$0-$65.6M

From Viking Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…